The Fetal Echocardiogram

Published on 21/06/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1815 times

2 The Fetal Echocardiogram

Background

As recently as the early 1990s, less than 10% of infants undergoing cardiac surgery in the first month of life received a diagnosis before birth. Today, reported rates of prenatal diagnosis frequently approach 50%.

A variety of maternal or fetal disorders may place a fetus at increased risk for congenital heart disease (CHD) (Table 2-1). If present, a fetal echocardiogram is indicated, and timely referral is recommended. Combined, approximately 5% of pregnancies are referred for in utero evaluation. Abnormal or unsatisfactory (the inability to establish normal) cardiac views obtained as part of an obstetric anatomic survey account for more than 20% of all referrals for in utero evaluation and lead to more than half of all prenatal diagnoses. The anatomic survey, a nearly universal mid-pregnancy ultrasound scan, includes a four-chamber (4C) view of the heart and, if possible, views of both outflow tracts. A positive family history accounts for another nearly 20% of all referrals. However, these are the source of less than 5% of all prenatal diagnoses.

TABLE 2-1 INDICATIONS FOR FETAL ECHOCARDIOGRAPHY

Maternal Indications Fetal Indications
Family history of CHD including prior child or pregnancy with CHD Abnormal obstetric screening ultrasound
Metabolic disorders (e.g., diabetes) Extracardiac abnormality
Exposure to teratogens Chromosomal abnormality
Exposure to prostaglandin synthetase inhibitors (ibuprofen) Arrhythmia
Infection (rubella, coxsackie virus, parvovirus B19) Hydrops
Autoimmune dx (e.g., Sjögren syndrome, SLE) Increased first trimester nuchal translucency
Familial inherited disorder (Marfan, Noonan syndromes) Multiple gestation and suspicion for twin-twin transfusion syndrome
In vitro fertilization  

Cardiac Embryology and In Utero Physiology

Overview

Echocardiography is the main diagnostic modality used to evaluate the fetal heart. The optimal timing for performance of a comprehensive transabdominal fetal echocardiogram is 18 to 20 weeks’ gestation. In select cases, late first trimester evaluation may be possible. Evaluation late in gestation is often complicated by a more “fixed” fetal position, which may limit the available acoustic windows.

A complete fetal echocardiogram includes two-dimensional (2D) evaluation of cardiac anatomy, spectral and color Doppler interrogation, and an assessment of cardiac function and rhythm. The components of a comprehensive evaluation are listed in Table 2-2, although not all may be visualized in every fetus at every examination. Similar to transthoracic imaging, fetal echocardiography depends on the ability to obtain standard views and evaluate structures in orthogonal views. The fetus may be very active, and the examiner may need to piece together many partial images to form a composite picture, particularly in the presence of complex CHD.

TABLE 2-2 COMPONENTS OF THE FETAL ECHOCARDIOGRAM

Overview

Biometric examination Cardiac imaging Doppler examination Measurement data Examination of rate and rhythm

Study Protocol

2D Images

The Four-Chamber View

The 4C view is the most important in a comprehensive examination of the fetal heart (Fig. 2-2A). The image is obtained in a transverse scanning plane (cross section). Once an acceptable image is obtained, cardiac position, axis, and size are assessed. Cardiac position can be influenced by the presence of extracardiac abnormalities that displace the heart within the thorax. Examples include congenital cystic adenomatoid malformations, diaphragmatic hernia (see Fig. 2-2B), and intrathoracic pulmonary sequestration. Normal cardiac axis can be confirmed by visually drawing a line from the spine to the sternum. The interventricular septum intersects that line at an approximately 45-degree angle (see Fig. 2-2C). Axis deviation can be seen in a variety of congenital heart lesions such as Ebstein’s anomaly of the TV (see Fig. 2-2D). Normally the fetal heart occupies about one third of the thorax. If there is any doubt on visual inspection, the circumference of each can be measured and compared (the cardiac-to-thoracic ratio). A normal cardiac-to-thoracic ratio is 0.55 ± 0.05 (see Fig. 2-2E).

Take time to assess all components of the 4C view. This view is abnormal in at least 50% of complex congenital heart disease.

Determination of left versus right ventricular morphology: The RV, in its normal position, is posterior to the sternum and identified by the presence of the moderator band (Fig. 2-3A). Postnatally, the trabeculation pattern may be quite distinct between the RV and LV; prenatally, this may be less conspicuous. Notice the slightly more apical location of the tricuspid annulus (see Fig. 2-3B) in comparison with the mitral valve.

The Outflow Tracts

Combined with the 4C view, visualization of both the right ventricular outflow tract (RVOT) and left ventricular outflow tract (LVOT) identifies well more than one half of all congenital heart lesions.

Doppler Evaluation

Rate and Rhythm Assessment

Once a comprehensive assessment of the cardiac anatomy is complete, the HR and rhythm are documented.

The HR is typically obtained using a Doppler tracing obtained with the sample volume just distal to the aortic valve (Fig. 2-7). The time from onset of flow from one beat to the next is obtained and then using the following conversion a rate in beats per minute (bpm) is calculated.

Suggested Reading

The Fetal Echocardiogram

1 Yagel S, Cohen SM, Achiron R. Examination of the fetal heart by five short-axis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol. 2001;17:367-369.

2 Allan LD, Paladini D. Prenatal measurement of cardiothoracic ratio in evaluation of heart disease. Arch Dis Child. 1990;65:20-23.

Retrospective evaluation of the normal cardiothoracic ratio and the impact of CHD or hydrops on the cardiothoracic ratio.

3 Schneider C, McCrindle BW, Carvalho JS, Hornberger LK, et al. Development of Z-scores for fetal cardiac dimensions from echocardiography. Ultrasound Obstet Gynecol. 2005;26:599-605.

Establishes Z scores for a set of measurements routinely obtained during a comprehensive fetal echocardiographic study. Allows for comparison with gestational age as well as femur length or biparietal diameter acknowledging variability in fetal size.

4 Al-Ghazali W, Chapman MG, Allan JG. Doppler assessment of the cardiac and uteroplacental circulations in normal and abnormal fetuses. Br J Obstet Gynaecol. 1988;95:575-580.

5 Api O, Carvalho J. Fetal dysrhythmias. Best Pract Res Clin Obstet Gynaecol. 2008;22:31-48.

Recent review of fetal dysrhythmias and their management.

6 Pasquini L, Gardiner HM. PR Interval: A comparison of electrical and mechanical methods in the fetus. Early Hum Dev. 2007;83:231-237.

Prospective comparison of the mechanical PR interval with a signal-averaged electrocardiogram obtained on the maternal abdomen. Discussion of the limitations of the mechanical PR interval, a surrogate for fetal cardiac electrical activity.

7 Huhta J. Fetal congestive heart failure. Semin Fetal Neonatal Med. 2005;10:542-552.

Reviews fetal heart failure and introduces a novel scoring system for serial evaluation, the Cardiovascular Profile Score.